Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scilex Holding Company

6.02
-0.1000-1.63%
Post-market: 5.74-0.2763-4.59%18:58 EDT
Volume:108.77K
Turnover:655.64K
Market Cap:41.54M
PE:-9.88
High:6.32
Open:6.06
Low:5.80
Close:6.12
Loading ...

Breakeven Is Near for Scilex Holding Company (NASDAQ:SCLX)

Simply Wall St.
·
04 Mar

BRIEF-Scilex Holding Says Terminates Sales Agreement With B. Riley, Cantor Fitzgerald, H.C. Wainwright Effective March 5

Reuters
·
04 Mar

Scilex Holding Co - Terminates Sales Agreement With B. Riley, Cantor Fitzgerald, H.c. Wainwright Effective March 5

THOMSON REUTERS
·
04 Mar

Scilex Holding Is Maintained at Buy by D. Boral Capital

Dow Jones
·
28 Feb

Scilex Holding Co - Scilex Pharma Enters License Agreement With Royaltyvest

THOMSON REUTERS
·
28 Feb

Scilex Holding Co - Royaltyvest Granted Exclusive Rights to Lido Products Outside U.S.

THOMSON REUTERS
·
28 Feb

Scilex says bankruptcy court extends lockup period on shares of Scilex dividend

TIPRANKS
·
31 Jan

Scilex Holding Company Announces That the U.S. Bankruptcy Court Has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to Its Stockholders as a Dividend to April 14, 2025

THOMSON REUTERS
·
31 Jan

Scilex Holding Faces Financial Strain Amid Form S-3 Ineligibility Crisis

TIPRANKS
·
23 Jan

Scilex announces U.S. FDA acknowledged submission of SNDA for ELYXYB

TIPRANKS
·
22 Jan

Scilex Holding Company Announces That the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for Elyxyb® in Acute Pain Indication

THOMSON REUTERS
·
22 Jan

Scilex Regains Compliance With Nasdaq Requirement for Continued Listing

MT Newswires Live
·
22 Jan

Scilex regains compliance with Nasdaq listing rules

TIPRANKS
·
22 Jan

Scilex Holding Company Announces That It Regains Nasdaq Compliance Under Listing Rule 5250(C)(1)

THOMSON REUTERS
·
22 Jan

Scilex Holding Company Announces Extension of the Maturity Date of Its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

THOMSON REUTERS
·
21 Jan

Scilex to file SNDA with FDA for ELYXYB

TIPRANKS
·
21 Jan

Scilex Holding Company Announces That It Will Be Filing Today of a Supplemental New Drug Application With the FDA for Elyxyb® in Acute Pain Indication

THOMSON REUTERS
·
21 Jan

SCLX Beats on Earnings as Product Line Expands

Zacks Small Cap Research
·
21 Jan

Scilex amends license agreement with Romeg Therapeutics

TIPRANKS
·
17 Jan

BRIEF-Scilex Holding Company Amends Its License Agreement With Romeg Therapeutics, LLC, For The Worldwide Rights To Commercialize Gloperba

Reuters
·
17 Jan